Bluetongue virus serotype 3 antigen

Bluetongue virus serotype 3 antigens are immunogenic proteins expressed by serotype 3 of Bluetongue virus, an orbivirus affecting ruminants and transmitted by midges. The antigenic repertoire includes the outer capsid proteins VP2 and VP5, which are key for inducing neutralizing antibodies and serotype determination, as well as core and nonstructural proteins like NS1, NS2, and NS3. VP2, in particular, is responsible for most of the serotype-specific neutralizing antibody response, while NS3 modulates host cell signaling (notably the MAPK/ERK pathway) and antagonizes host interferon responses. “Bluetongue virus serotype 3 antigens” is not a standard drug or biologic target, but rather a collection of viral immunogens relevant for diagnostics and vaccine development. This entry should not be considered a standardized therapeutic target due to lack of specificity and the plural reference to a heterogeneous collection of antigens.

Other names

BTV-3 antigensBTV serotype 3 antigensBluetongue virus serotype 3 proteins

For vaccines, induction of serotype-specific neutralizing antibodies—primarily targeting outer capsid protein VP2. For inhibitors like U0126, block activation of the MAPK/ERK pathway hijacked by BTV NS3 to impair viral replication.